We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Marina Biotech Reports Interim Results of Their Phase 2-Enabling Toxicology Study for CEQ508

News   Feb 25, 2011

 
Marina Biotech Reports Interim Results of Their Phase 2-Enabling Toxicology Study for CEQ508
 
 
Advertisement
 

RELATED ARTICLES

Once-daily Topical Treatment Improves Chronic Plaque Psoriasis

News

In Phase 2b clinical trials, a once-daily roflumilast cream showed significant improvements in psoriasis signs and symptoms, in as early as two weeks.

READ MORE

Robot Jaws Help Test Potential of Chewing Gum as Drug Delivery Method

News

Medicated chewing gum has been recognized as a new advanced drug delivery method but currently, there is no "gold standard" for testing drug release in vitro. Researchers have now designed a chewing robot with built-in humanoid jaws that could aid the development of medicated chewing gum.

READ MORE

Trial Assessing Antiviral Drug DAS181 Against COVID-19 Begins Enrolling Patients

News

Keck Medicine of USC physicians are enrolling patients as part of an international clinical trial, designed to assess the safety and efficacy of the antiviral drug DAS181, as a possible treatment for patients with severe COVID-19.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE